|
The program will support and fund clinical, descriptive and epidemiological studies of hereditary bleeding disorders. While inquiries of correlations between clinical and biological or genetic determinants are expected, the program will not support strictly fundamental research. For the purpose of this program, hereditary bleeding disorders include hemophilia A and B including inhibitor patients, Von Willebrand disease, and other rare inherited bleeding disorders.
|
|
